Company:  OPGEN INC (OPGN)
Form Type:  S-3
Filing Date:  8/9/2021 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  240-813-1260 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.54  
Change: 
-0.075 (-4.66%)  
Trade Time: 
12:50 PM EST  
Market Cap: 
$59.79M
Trade OPGN now with

© 2021  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. The Company is developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. OpGen's proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections.
Register and access this filing in:     
  FORM S-3
    Subject to Completion, Dated August 9, 2021
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    RISK FACTORS
    USE OF PROCEEDS
    PLAN OF DISTRIBUTION
    Primary Offerings by the Company
    DESCRIPTION OF SECURITIES
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND ADDITIONAL INFORMATION
    PART II
      Item 14. Other Expenses of Issuance and Distribution.
      Item 15. Indemnification of Directors and Officers.
      Item 16. Exhibits.
      Item 17. Undertakings.
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 5.1
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm